Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001918845-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 8, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
11,910
Total Value
$121,728.93
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Apr 6, 2026 | Exercise/Conversion | 3,970 | $12.65 | $50,220.50 | 7,592 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 6, 2026 | Sale | 3,970 | $18.01 | $71,508.43 | 3,622 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Apr 6, 2026 | Exercise/Conversion | 3,970 | $0.00 | $0.00 | 210,530 | Direct | โ | View Details |